Seminars in Nephrology
Volume 27, Issue 2 , Pages 208-222 , March 2007

Mining the Genome for Susceptibility to Diabetic Nephropathy: The Role of Large-Scale Studies and Consortia

  • Sudha K. Iyengar, PhD

      Affiliations

    • Departments of Epidemiology and Biostatistics, Ophthalmology and Genetics, Case Western Reserve University, Cleveland, OH.
    • Corresponding Author InformationAddress reprint requests to Dr. Sudha K. Iyengar, Case Western Reserve University, Wolstein Research Building, 1315, 2103 Cornell Rd, Cleveland, OH 44106-7281.
    • ,
  • Barry I. Freedman, MD

      Affiliations

    • Department of Internal Medicine/Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC.
    • ,
  • John R. Sedor, MD

      Affiliations

    • Departments of Medicine and Physiology and Biophysics, Case School of Medicine and Kidney Disease Research Center, Rammelkamp Center for Research and Education, MetroHealth System Campus, Cleveland, OH.

References 

  1. Seaquist ER, Goetz FC, Povey S. Diabetic nephropathy: an hypothesis regarding genetic susceptibility for the disorder. Minn Med. 1986;69:457–459
  2. Scalvini T, Spandrio S, di-Stefano O, et al. Severe microvascular disease in type II diabetes of early onset (A family study). Acta Diabetol Lat. 1989;26:58–74
  3. Seaquist ER, Goetz FC, Rich S, et al. Familial clustering of diabetic kidney disease (Evidence for genetic susceptibility to diabetic nephropathy). N Engl J Med. 1989;320:1161–1165
  4. Pettitt DJ, Saad MF, Bennett PH, et al. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:438–443
  5. Kalter LO, Van-Dyk DJ, Leibovici L, et al. Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes. 1991;40:204–210
  6. Freedman BI, Spray BJ, Tuttle AB, et al. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis. 1993;21:387–393
  7. Krolewski AS, Doria A, Magre J, et al. Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus. J Am Soc Nephrol. 1992;3:S9–S17
  8. Quinn M, Angelico MC, Warram JH, et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940–945
  9. Imperatore G, Hanson RL, Pettitt DJ, et al. Pima Diabetes Genes Group Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes. 1998;47:821–830
  10. Moczulski DK, Rogus JJ, Antonellis A, et al. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes. 1998;47:1164–1169
  11. Yu H, Bowden DW, Spray BJ, et al. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. Hypertension. 1998;31:906–911
  12. Rogus JJ, Krolewski AS. Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk. Am J Hum Genet. 1996;59:1376–1381
  13. Hoogwerf BJ, Brouhard BH. Glycemic control and complications of diabetes mellitus: practical implications of the Diabetes Control and Complications Trial (DCCT). Cleve Clin J Med. 1994;61:34–37
  14. Jones SL, Viberti GC. Hypertension and microalbuminuria as predictors of diabetic nephropathy. Diabetes Metab. 1989;15:327–332
  15. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  16. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483
  17. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease (The Modification of Diet in Renal Disease Study). Ann Intern Med. 1995;123:754–762
  18. de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol. 2006;17:2120–2126
  19. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, et al. Urinary albumin excretion (An independent predictor of ischemic heart disease). Arterioscler Thromb Vasc Biol. 1999;19:1992–1997
  20. Fogarty DG, Hanna LS, Wantman M, et al. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes. 2000;49:1057–1063
  21. Langefeld CD, Beck SR, Bowden DW, et al. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis. 2004;43:796–800
  22. Imperatore G, Knowler WC, Pettitt DJ, et al. Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes. 2000;49:1049–1056
  23. Fogarty DG, Rich SS, Hanna L, et al. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int. 2000;57:250–257
  24. Forsblom CM, Kanninen T, Lehtovirta M, et al. Heritability of albumin excretion rate in families of patients with type II diabetes. Diabetologia. 1999;42:1359–1366
  25. Fioretto P, Steffes MW, Barbosa J, et al. Is diabetic nephropathy inherited? (Studies of glomerular structure in type 1 diabetic sibling pairs). Diabetes. 1999;48:865–869
  26. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial (The Diabetes Control and Complications Trial Research Group). Diabetes. 1997;46:1829–1839
  27. Biesenbach G, Janko O, Zazgornik J. Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. Nephrol Dial Transplant. 1994;9:1097–1102
  28. Svensson M, Nystrom L, Schon S, et al. Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care. 2006;29:538–542
  29. Kussman MJ, Goldstein H, Gleason RE. The clinical course of diabetic nephropathy. JAMA. 1976;236:1861–1863
  30. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241–247
  31. Burton PR, Palmer LJ, Jacobs K, et al. Ascertainment adjustment: where does it take us?. Am J Hum Genet. 2000;67:1505–1514
  32. Dawson DV, Elston RC. A bivariate problem in human genetics: ascertainment of families through a correlated trait. Am J Med Genet. 1984;18:435–448
  33. Elston RC, Sobel E. Sampling considerations in the gathering and analysis of pedigree data. Am J Hum Genet. 1979;31:62–69
  34. Ginsburg E, Malkin I, Elston RC. Sampling correction in pedigree analysis. Stat Appl Genet Mol Biol. 2003;2:Article 2
  35. Ginsburg E, Malkin I, Elston RC. Sampling correction in linkage analysis. Genet Epidemiol. 2004;27:87–96
  36. Knowler WC, Coresh J, Elston RC, et al. The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. J Diabetes Complications. 2005;19:1–9
  37. Mueller PW, Rogus JJ, Cleary PA, et al. Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol. 2006;17:1782–1790
  38. Bowden DW, Colicigno CJ, Langefeld CD, et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int. 2004;66:1517–1526
  39. Shimazaki A, Kawamura Y, Kanazawa A, et al. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes. 2005;54:1171–1178
  40. Janssen B, Hohenadel D, Brinkkoetter P, et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes. 2005;54:2320–2327
  41. Yu H, Bowden DW, Spray BJ, et al. Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J Am Soc Nephrol. 1996;7:2559–2564
  42. Freedman BI, Yu H, Spray BJ, et al. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int. 1997;51:819–825
  43. Freedman BI, Rich SS, Yu H, et al. Linkage heterogeneity of end-stage renal disease on human chromosome 10. Kidney Int. 2002;62:770–774
  44. Yu H, Sale M, Rich SS, et al. Evaluation of markers on human chromosome 10, including the homologue of the rodent Rf-1 gene, for linkage to ESRD in black patients. Am J Kidney Dis. 1999;33:294–300
  45. Vardarli I, Baier LJ, Hanson RL, et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int. 2002;62:2176–2183
  46. Freedman BI, Beck SR, Rich SS, et al. A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension. 2003;42:291–296
  47. Iyengar SK, Fox KA, Schachere M, et al. Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. J Am Soc Nephrol. 2003;14:S195–S201
  48. Freedman BI, Bowden DW, Rich SS, et al. A genome scan for all-cause end-stage renal disease in African Americans. Nephrol Dial Transplant. 2005;10:2719–2727
  49. Krolewski AS, Poznik GD, Placha G, et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int. 2006;69:129–136
  50. Osterholm AM, He B, Pitkaniemi J, et al. Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int. 2006;71:140–145
  51. Iyengar SK, Abboud HE, Goddard KAB, et al, and on behalf of the Family Investigation of Nephropathy and Diabetes. Genome-wide scans for diabetic nephropathy and albuminuria in multi-ethnic populations. the Family Investigation of Nephropathy and Diabetes. Diabetes. In press.
  52. McKnight AJ, Maxwell AP, Sawcer S, et al. A genome-wide DNA microsatellite association screen to identify chromosomal regions harboring candidate genes in diabetic nephropathy. J Am Soc Nephrol. 2006;17:831–836
  53. An P, Freedman BI, Hanis CL, et al. Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the national heart, lung, and blood institute family blood pressure program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. Diabetes. 2005;54:909–914
  54. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76–80
  55. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320–323
  56. Tsuchiya T, Schwarz PE, Bosque-Plata LD, et al. Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab. 2006;89:174–184
  57. Zschocke J, Nebel A, Wicks K, et al. Allelic variation in the CNDP1 gene and its lack of association with longevity and coronary heart disease. Mech Ageing Dev. 2006;127:817–820
  58. Ewens KG, George RA, Sharma K, et al. Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes. 2005;54:3305–3318
  59. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993;52:506–516
  60. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am J Hum Genet. 1998;62:450–458
  61. Freimer NB, Sabatti C. Guidelines for association studies in human molecular genetics. Hum Mol Genet. 2005;14:2481–2483
  62. Ehm MG, Nelson MR, Spurr NK. Guidelines for conducting and reporting whole genome/large-scale association studies. Hum Mol Genet. 2005;14:2485–2488
  63. The International HapMap Consortium. The International HapMap Project. Nature. 2003;426:789–796
  64. The International HapMap Consortium. Integrating ethics and science in the International HapMap Project. Nat Rev Genet. 2004;5:467–475
  65. Hinds DA, Seymour AB, Durham LK, et al. Application of pooled genotyping to scan candidate regions for association with HDL cholesterol levels. Hum Genomics. 2004;1:421–434
  66. Barrett JC, Cardon LR. Evaluating coverage of genome-wide association studies. Nat Genet. 2006;38:659–662
  67. Koopman RJ, Mainous AG, Liszka HA, et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med. 2006;4:427–432
  68. Ong AC, Harris PC. Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int. 2005;67:1234–1247
  69. Epidemiology of Diabetes Interventions and Complications (EDIC) (Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort). Diabetes Care. 1999;22:99–111
  70. Lloyd CE, Stephenson J, Fuller JH, et al. A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study. Diabetes Care. 1996;19:219–225
  71. Roglic G, Colhoun HM, Stevens LK, et al. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med. 1998;15:418–426
  72. Pettersson-Fernholm K, Forsblom C, Perola M, et al. Polymorphisms in the nephrin gene and diabetic nephropathy in type 1 diabetic patients. Kidney Int. 2003;63:1205–1210
  73. Boger CA, Haak T, Gotz AK, et al. Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study. Int J Clin Pharmacol Ther. 2006;44:364–374
  74. Cordovado SK, Hancock LN, Simone AE, et al. High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404. Tissue Antigens. 2005;65:448–458
  75. Hancock LN, Cordovado SK, Hendrix M, et al. Identification of two novel DQA1 alleles, DQA1*0107 and DQA1*0602, by sequence-based typing in the GoKinD population. Hum Immunol. 2005;66:1248–1253
  76. van der Sman-de Beer , Verhagen C, Rombach SM, et al. ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis. Kidney Int. 2005;68:2237–2243
  77. Jager KJ, Merkus MP, Boeschoten EW, et al. NECOSAD Study Group Dialysis in The Netherlands: the clinical condition of new patients put into a European perspective (Netherlands Cooperative Study on the Adequacy of Dialysis phase 1). Nephrol Dial Transplant. 1999;14:2438–2444

 Supported by research grants U01DK57292, U01DK57293, UO1DK57298, RO1DK070942, and R01DK064719 from the National Institute of Diabetes and Digestive and Kidney Diseases and the Kidney Foundation of Ohio.

PII: S0270-9295(07)00005-8

doi: 10.1016/j.semnephrol.2007.01.004

Seminars in Nephrology
Volume 27, Issue 2 , Pages 208-222 , March 2007

Article Tools

* Image Usage & Resolution